Bo Qu

Bo Qu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
ZLZesheng Li
Zesheng Li
YDYuzhu Di
Yuzhu Di
LJLubo Jin
Lubo Jin
BQBo Qu
Bo Qu
HZHongyue Zhang
Hongyue Zhang
Gallium-based liquid metals have been extensively studied in the field of biomedical engineering, including applications in tumor and inflammatory disease therapy, as well as targeted drug delivery. Among these, leveraging the photothermal effect of gallium liquid metals enables effective treatment of heat-sensitive cells in tumor regions and enhances the diffusion capability of liquid metal microdroplets. However, research on the active treatment of ulcerative colitis (UC) using photothermal therapy with liquid metals remains unexplored. This study focuses on constructing an active composite colloidal motor based on gallium indium liquid metal alloy, using liquid metal microdroplets as the core. Through layer-by-layer assembly of polyelectrolytes, a liquid metal active droplet loaded with the drug mesalazine (5-aminosalicylic acid), named as LMAD-A was developed. Under asymmetric light fields generated by NIR-II light source irradiation, LMAD-A exhibits autonomous locomotion, achieving an effective diffusion coefficient more than 800 times greater than that of Brownian motion in liquid metal microdroplets of similar size. Furthermore, LMAD-A demonstrates phototactic behavior, moving toward the NIR light source autonomously. Through in vitro and in vivo experiments in mice, it was verified that LMAD-A can aggregate, deform, and fuse in the mouse colon under photothermal effects, leading to enhanced release of the loaded drug. In simulated treatments, LMAD-A significantly alleviated DSS-induced colitis in mice, confirming the targeted therapeutic capability of active liquid metal microdroplets as an active therapeutic agent in UC-affected regions.

9 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
YDYuzhu Di
Yuzhu Di
JDJiaxing Deng
Jiaxing Deng
ZHZiyou Hong
Ziyou Hong
ZLZhirui Liu
Zhirui Liu
LJLubo Jin
Lubo Jin
BQBo Qu
Bo Qu
Background: Inflammatory bowel disease (IBD) involves chronic intestinal inflammation, epithelial barrier disruption, and dysbiosis, with environmental factors playing a significant role in its pathogenesis. Previous work revealed that cold exposure alleviates colitis in mice; this study extends that finding by demonstrating that cold exposure enhances intestinal regeneration even in healthy mice, upregulating proliferation markers (Mki67, PCNA, Cyclin D1). Methods: Applying this pro-regenerative effect to a colitis model, we investigated the underlying mechanisms through multi-omics analysis, transmission electron microscopy (TEM), immunofluorescence, and pathological staining as well as 16S rRNA sequencing. Results: We found that cold exposure activates intestinal epithelial proliferation pathways. Further analysis indicated that cold exposure induces colonic stem cell regeneration, upregulating stem cell markers Lgr5 and Ascl2. Notably, colonic transcriptomic profiling revealed the emergence of a Paneth-like cell phenotype, characterized by altered expression of specific lineage genes. Furthermore, cold exposure simultaneously promoted the accumulation of secretory granules and upregulated the expression of antimicrobial peptide genes (such as Lysozyme and Defa) in ileal Paneth cells. This enhanced ileal antimicrobial defense effectively reshaped the gut microbiota in inflamed intestines. Conclusions: This research elucidates a mechanism whereby cold adaptation promotes mucosal repair by integrating localized colonic epithelial regeneration with enhanced ileal Paneth cell-mediated antimicrobial defense. This offers compelling new perspectives on how environmental factors, such as cold exposure, could influence the pathophysiology of IBD and contribute to intestinal regeneration, which may provide foundational theoretical support for the future diagnosis and treatment of IBD.

22 February 2026 in Micromachines
Verified
Journal Article
Open access
PDF file
HZHongyue Zhang
Hongyue Zhang
YDYuzhu Di
Yuzhu Di
LJLubo Jin
Lubo Jin
SYShuai Yang
Shuai Yang
ZLZesheng Li
Zesheng Li
BQBo Qu
Bo Qu
Magnetic nanoparticles, with their excellent biocompatibility and biodegradability, serve as ideal materials for constructing targeted drug delivery systems. Iron oxide (Fe3O4) nanoparticles, controllably prepared via methods such as solvothermal synthesis, can be combined with mesoporous silica to construct magnetically steerable nanorobots. Such robots enable efficient drug loading and precise delivery. To address challenges in the treatment of Inflammatory Bowel Disease (IBD), including the significant side effects of systemic drugs and the low oral bioavailability and poor colonic targeting of novel food-derived drugs (e.g., capsaicin with anti-inflammatory activity), this study designed capsaicin-loaded iron oxide-mesoporous silica composite nanorobots (Cap-M@mSbots). Driven by a rotating gradient magnetic field of up to 80 mT, Cap-M@mSbots achieve large-scale emergent collective locomotion, with a maximum collective locomotion velocity reaching 180.7 μm/s, and are capable of long-distance movement overcoming millimeter-scale obstacles. This system can be actively propelled to colonic lesion sites under magnetic guidance, achieving targeted drug enrichment and sustained release, thereby offering a novel strategy for the targeted therapy of IBD.